AK Clinical Research is proud to be a key partner in a groundbreaking initiative to develop the world’s first wearable device for the treatment of epilepsy! We are thrilled to announce that our collaborative effort with Remagine Labs, the Monash Institute of Pharmaceutical Sciences (MIPS) and University of Melbourne, has secured a $3 million CRC-P grant. This grant will propel the development of this innovative 'patch' as we prepare for clinical trials. Have a Read: https://lnkd.in/gFVUi_C4 #MedicalInnovation #WearableTech #ClinicalResearch #HealthcareInnovation #Biotechnology #ClinicalTrials
We were delighted to see a $3 million CRC-P #grant awarded to these Melbourne-based researchers who are developing the world’s first wearable device to treat #epilepsy. The team, led by biotechnology company Remagine Labs , the University of Melbourne, the Monash Institute of Pharmaceutical Sciences (MIPS), and AK Clinical Research, will use the grant to further develop the 'patch' for clinical trials. It was a pleasure to be part of the grant application process and we can't wait to see how this gamechanging system progresses, especially considering its potential to deliver other drugs to people living with a range of chronic diseases. https://lnkd.in/gFVUi_C4